These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 829708)

  • 21. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
    Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
    Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
    Kim JA; Huh W; Lee KW; Kim SJ; Kim YG; Kim DJ; Joh JW; Oh HY
    Transplant Proc; 2004 Jun; 36(5):1434-7. PubMed ID: 15251352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of uniplant on liver function in Egyptian women with asymptomatic hepatitis B virus infection.
    Shaamsh AH; Salem HT; Shaaban MM; Ghaneima SA; Helal SR
    Afr J Reprod Health; 2005 Apr; 9(1):24-31. PubMed ID: 16104652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B core antibody in volunteer blood donors in Kenya.
    Bowry TR; Ahmad Z; Chemtai AK
    East Afr Med J; 1981 Aug; 58(8):570-5. PubMed ID: 7297460
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
    Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
    Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anicteric viral hepatitis in blood donors. A clinico-pathological and Australia antigen study in Singapore.
    Fung WP; Ong YW; Kwa SB; Tan KK; Yap EH; Simons MJ
    Med J Aust; 1971 Oct; 2(18):888-91. PubMed ID: 5124075
    [No Abstract]   [Full Text] [Related]  

  • 28. The incidence of Australia antigen in hospital staff members.
    Powell E; Gordon S; Raik E
    Med J Aust; 1975 Oct; 2(15):595-7. PubMed ID: 1196224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Liver disease in healthy blood donors associated with presence of hepatitis B antibody.
    Boyes BE; Woolf IL; Whittaker JS; Tapp E; Jones DM; Renton PH; Stratton F; McSween R; Dymock IW
    Gut; 1974 Apr; 15(4):341. PubMed ID: 4834573
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.
    Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M
    Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of Australia-antibody in blood donors. Study of liver histology in donors and post-transfusion hepatitis in recipients.
    Reinicke V; Poulsen H; Banke O; Dybkjaer E
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):753-6. PubMed ID: 4205739
    [No Abstract]   [Full Text] [Related]  

  • 32. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Australia-SH antigen in serum. A comparison of the electron microscopical, agar gel double diffusion, and complement fixation tests.
    Solaas MH
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):151-63. PubMed ID: 4211912
    [No Abstract]   [Full Text] [Related]  

  • 34. Natural history of hepatitis B in perinatally infected carriers.
    Boxall EH; Sira J; Standish RA; Davies P; Sleight E; Dhillon AP; Scheuer PJ; Kelly DA
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F456-60. PubMed ID: 15321970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt.
    Gad A; Tanaka E; Orii K; Kafumi T; Serwah AE; El-Sherif A; Nooman Z; Kiyosawa K
    J Med Virol; 2000 Feb; 60(2):177-81. PubMed ID: 10596018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TT virus infection in chronic liver disease.
    Tangkijvanich P; Theamboonlers A; Hirsch P; Kullavanijaya P; Suwangool P; Poovorawan Y
    Hepatogastroenterology; 1999; 46(26):1053-8. PubMed ID: 10370666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N; Ozen H; Yüce A; Gürakan F
    Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association between Class I HLA alleles and HBs antigen carrier status among blood donors in Senegal].
    Dieye A; Obami-Itou V; Barry MF; Raphenon G; Thiam A; Ndiaye R; Ndiaye M; Diaw ML; Diakhate L
    Dakar Med; 1999; 44(2):166-70. PubMed ID: 11957279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the Australia antigen and of the corresponding antibody in blood donors in Paris.
    Soulier JP; Courouce-Pauty AM; Benamon-Djiane D
    Vox Sang; 1970; 19(3):345-51. PubMed ID: 4993786
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B antigen in a rural community in Kenya.
    Bagshawe A; Nganda TN
    Trans R Soc Trop Med Hyg; 1973; 67(5):663-70. PubMed ID: 4779112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.